Our Research

Abstract XXY chromosomes and clinical data pathways illustrating the GentileX research framework.

Beginning with Klinefelter syndrome (47,XXY), GentileX has developed a proprietary methodology to address a specific recognition failure: meaningful clinical findings can remain fragmented across time, specialties, and records, delaying consideration of appropriate evaluation.

The methodology connects relevant findings through an explainable, clinician-guided review pathway and helps professionals recognize when further specialist evaluation may be appropriate. It is designed to support—not replace—clinical judgment and is not a diagnostic system.

Clinical philosophy · Explainable review · Human judgment · Responsible referral ·

Clinical philosophy · Explainable review · Human judgment · Responsible referral ·

Research roadmap · Evidence first · Validation before deployment ·

Expansion only with proof ·

Research roadmap · Evidence first · Validation before deployment · Expansion only with proof ·

The methodology is ready to advance through four partnership-led workstreams.

Recognition failure — Addressing how relevant findings become separated across years, clinicians, specialties, and records, even when confirmation is available through established testing.

Explainable clinical review — Translating the methodology into a clinician-reviewable software pathway without exposing patients to automated diagnosis.

Independent validation — Evaluating performance, limitations, bias, governance, workflow fit, and patient safety before clinical deployment.

Responsible expansion — Beginning with XXY and expanding only after condition-specific evidence and validation.

Development pathway: proprietary methodology → software build → independent validation → clinical workflow testing → governed integration → commercialization.